CN116234590A - Dialysis systems and methods - Google Patents

Dialysis systems and methods Download PDF

Info

Publication number
CN116234590A
CN116234590A CN202180064900.0A CN202180064900A CN116234590A CN 116234590 A CN116234590 A CN 116234590A CN 202180064900 A CN202180064900 A CN 202180064900A CN 116234590 A CN116234590 A CN 116234590A
Authority
CN
China
Prior art keywords
dialysis
fluid
flow rate
blood pump
pump
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202180064900.0A
Other languages
Chinese (zh)
Inventor
迈克尔·爱德华·霍佳德
迈克尔·阿拉贡
D·胡
艾米·伊丽莎白·科尔多克
伊莱恩·卡瓦利耶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aosai Medical Co
Original Assignee
Aosai Medical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aosai Medical Co filed Critical Aosai Medical Co
Publication of CN116234590A publication Critical patent/CN116234590A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/342Adding solutions to the blood, e.g. substitution solutions
    • A61M1/3424Substitution fluid path
    • A61M1/3431Substitution fluid path upstream of the filter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1601Control or regulation
    • A61M1/1603Regulation parameters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3643Priming, rinsing before or after use
    • A61M1/3644Mode of operation
    • A61M1/3646Expelling the residual body fluid after use, e.g. back to the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3643Priming, rinsing before or after use
    • A61M1/3644Mode of operation
    • A61M1/3649Mode of operation using dialysate as priming or rinsing liquid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3643Priming, rinsing before or after use
    • A61M1/3644Mode of operation
    • A61M1/365Mode of operation through membranes, e.g. by inverted trans-membrane pressure [TMP]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621Extra-corporeal blood circuits
    • A61M1/3639Blood pressure control, pressure transducers specially adapted therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00General characteristics of the apparatus
    • A61M2205/33Controlling, regulating or measuring
    • A61M2205/3331Pressure; Flow
    • A61M2205/3334Measuring or controlling the flow rate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M39/00Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
    • A61M39/22Valves or arrangement of valves
    • A61M39/28Clamping means for squeezing flexible tubes, e.g. roller clamps

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • External Artificial Organs (AREA)

Abstract

Dialysis systems and methods are described that can include a number of features. The described dialysis system can provide dialysis treatment to a patient in a comfortable environment of the patient's own home. The dialysis system can be configured to prepare purified water in real time from a tap water source for use in producing a dialysate solution. The dialysis system described also includes features that facilitate the patient's self-management of the treatment.

Description

透析系统以及方法Dialysis systems and methods

相关申请的交叉引用Cross References to Related Applications

本申请要求2020年8月5日提交的美国临时申请第63/061,623号的优先权的利益,该美国临时申请据此通过引用以其整体并入本文。This application claims the benefit of priority to U.S. Provisional Application No. 63/061,623, filed August 5, 2020, which is hereby incorporated by reference in its entirety.

通过引用并入incorporated by reference

在本说明书中提到的所有出版物和专利申请都通过引用并入本文,其通过引用并入本文的程度与每个单独的出版物或专利申请被具体地和单独地指明通过引用并入的程度相同。All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference. to the same extent.

领域field

本公开总体上涉及透析系统。更具体地,本公开涉及将置换流体(replacementfluid)、生理盐水或其他稀释流体递送到血液流动路径中。本公开特别地适用于更长时间的治疗,通过自动化增加了用户的便利性,并且减少了与自动生理盐水递送相关联的干扰警报。The present disclosure generally relates to dialysis systems. More specifically, the present disclosure relates to the delivery of replacement fluids, saline, or other diluting fluids into blood flow paths. The present disclosure is particularly applicable to longer periods of therapy, increasing user convenience through automation, and reducing nuisance alarms associated with automated saline delivery.

背景background

目前,美国有数以十万计的终末期肾病患者。大多数患者需要透析才能存活。许多患者在透析中心接受透析治疗,这可能会给患者带来苛刻的、限制性的和累人的日程安排。在中心接受透析的患者通常每周必须去中心至少三次,并且每次在椅子上坐3至4小时,在这段时间里让毒素和多余的流体从他们的血液中过滤掉。在治疗后,患者必须等待进针部位止血和血压恢复正常,这需要从他们日常生活中的其他更有意义的活动中抽出更多的时间。此外,在中心的患者必须遵守严格的时间安排,因为典型的中心一天要治疗三到五个班次的患者。因此,许多每周透析三次的人抱怨在一次透析后的至少几个小时里,他们感到筋疲力尽。Currently, there are hundreds of thousands of patients with end-stage renal disease in the United States. Most patients require dialysis to survive. Many patients receive dialysis treatment at a dialysis center, which can create a demanding, restrictive and tiring schedule for the patient. Patients on dialysis at the center typically have to go to the center at least three times a week and sit in a chair for three to four hours each time, during which time toxins and excess fluid are filtered from their blood. After treatment, patients must wait for the needle site to stop bleeding and blood pressure to return to normal, which takes more time away from other, more meaningful activities in their daily lives. Additionally, patients at the center must adhere to a strict schedule, as a typical center treats patients on three to five shifts a day. As a result, many people on dialysis three times a week complain of feeling exhausted for at least a few hours after a session.

市场上的许多透析系统在透析治疗之前、期间和之后都需要技术人员的大量投入和关注。在治疗前,技术人员通常需要手动将患者血液管组(patient blood tubing sets)安装到透析系统上,将管组连接到患者和透析器上,并且在治疗之前手动灌注管组以排出管组中的空气。在治疗期间,技术人员通常需要监测静脉压力和液位(fluid level),并向患者施用大剂量的生理盐水和/或肝素。在治疗后,技术人员通常需要将管组中的血液返回给患者,并排空透析系统。大多数透析系统的低效率以及在这一过程中需要大量技术人员的参与使得患者很难在大型治疗中心以外的地方接受透析治疗。Many dialysis systems on the market require a lot of input and attention from the technician before, during and after dialysis treatment. Prior to treatment, technicians typically need to manually install patient blood tubing sets onto the dialysis system, connect the tubing sets to the patient and the dialyzer, and manually prime the tubing sets to drain the tubing sets prior to treatment air. During treatment, technicians typically need to monitor venous pressure and fluid levels, and administer large doses of saline and/or heparin to the patient. After treatment, the technician is usually required to return the blood in the tubing set to the patient and drain the dialysis system. The inefficiency of most dialysis systems and the large number of technicians involved in the process make it difficult for patients to receive dialysis outside of large treatment centers.

考虑到在中心进行透析的苛刻性质,许多患者已将家庭透析作为一种选择。家庭透析为患者提供了时间安排的灵活性,因为家庭透析允许患者选择治疗时间,以安排时间去做其他活动,例如去工作或照顾家庭成员。不幸的是,目前的透析系统通常不适合在患者家中使用。其中一个原因是,目前的系统太大且太笨重,不适合放在普通家庭中。目前的透析系统也是能源效率低下的,因为它们使用大量的能量来加热大量的水以供适当使用。尽管一些家庭透析系统是可用的,但是它们通常难以安装和使用。因此,慢性病患者的大多数透析治疗都在透析中心进行。Given the demanding nature of in-center dialysis, many patients have turned to home dialysis as an option. Home dialysis offers patients flexibility in scheduling because home dialysis allows patients to choose the time of treatment to allow time for other activities, such as going to work or caring for family members. Unfortunately, current dialysis systems are often not suitable for use in the patient's home. One reason for this is that current systems are too large and unwieldy to fit in the average home. Current dialysis systems are also energy inefficient because they use a lot of energy to heat large volumes of water for proper use. Although some home dialysis systems are available, they are often difficult to install and use. Therefore, most dialysis treatments for chronically ill patients are performed in dialysis centers.

血液透析也可以在急性医院环境中进行,可以用于已住院的当前透析患者,或者可以用于患有急性肾损伤的患者。在这些护理环境中,通常是在医院病房,不容易获得足够纯度的水来产生透析液。因此,急性情况下的血液透析机依赖大量的预混合透析液,这些透析液通常装在大袋中,并且工作人员处理起来很麻烦。可替代地,血液透析机可以连接到便携式R0(反渗透(reverse osmosis))机器或其他类似的水净化装置。这引入了必须要进行管理、运输和消毒的另一件独立的设备。Hemodialysis can also be performed in an acute hospital setting, for current dialysis patients who are hospitalized, or for patients with acute kidney injury. In these care settings, typically hospital wards, water of sufficient purity to produce dialysate is not readily available. As a result, hemodialysis machines in acute situations rely on large quantities of premixed dialysate, often in large bags, and are cumbersome for staff to handle. Alternatively, the hemodialysis machine can be connected to a portable RO (reverse osmosis) machine or other similar water purification device. This introduces another separate piece of equipment that must be managed, transported and sterilized.

本公开的概述Overview of the Disclosure

提供了一种提高透析管的性能的方法,该透析管包括动脉管线并且还包括将流体源连接到透析管的流体递送管线,该方法包括以下步骤:闭塞透析管的动脉管线;打开或释放与流体递送管线接合的夹紧机构;调控与透析管接合的血液泵的泵速,以增加透析管内的流体压力;以及将流体从流体源通过流体递送管线递送到透析管中。A method of improving the performance of a dialysis tubing comprising an arterial line and further comprising a fluid delivery line connecting a fluid source to the dialysis tubing is provided, the method comprising the steps of: occluding the arterial line of the dialysis tubing; A clamping mechanism engaging the fluid delivery line; regulating a pump speed of a blood pump engaged with the dialysis tubing to increase fluid pressure within the dialysis tubing; and delivering fluid from a fluid source through the fluid delivery line into the dialysis tubing.

在一些实施例中,调控血液泵的泵速包括将血液泵的流速从第一流速增加到第二流速。In some embodiments, modulating the pump speed of the blood pump includes increasing the flow rate of the blood pump from a first flow rate to a second flow rate.

在其他实施例中,调控血液泵的泵速包括将血液泵的流速从第一流速降低到第二流速。In other embodiments, modulating the pump speed of the blood pump includes decreasing the flow rate of the blood pump from the first flow rate to the second flow rate.

在一个实施例中,调控血液泵的泵速包括使血液泵的流速脉冲化。In one embodiment, modulating the pump speed of the blood pump includes pulsating the flow rate of the blood pump.

在一些示例中,调控血液泵的泵速包括将血液泵的流速从大约320ml/min降低到大约180ml/min。In some examples, regulating the pump rate of the blood pump includes decreasing the flow rate of the blood pump from about 320 ml/min to about 180 ml/min.

在另一实施例中,该方法还包括自动调度闭塞步骤、打开步骤和调控步骤以在透析治疗期间周期性地发生。In another embodiment, the method further includes automatically scheduling the occluding step, the opening step, and the modulating step to occur periodically during the dialysis treatment.

在一个实施例中,在打开或释放夹紧机构之后,由于流体递送管线的前延长夹紧(prior extended clamping),流体递送管线的一部分保持闭塞。In one embodiment, after opening or releasing the clamping mechanism, a portion of the fluid delivery line remains occluded due to prior extended clamping of the fluid delivery line.

在另一实施例中,在打开或释放夹紧机构之后,由于流体递送管线的前延长夹紧,流体递送管线的一部分保持部分地闭塞。In another embodiment, after opening or releasing the clamping mechanism, a portion of the fluid delivery line remains partially occluded due to the clamping of the forward extension of the fluid delivery line.

在一个示例中,该方法还包括以下步骤:将动脉管线解除闭塞;关闭或压缩与流体递送管线接合的夹紧机构;以及启动透析治疗。In one example, the method further includes the steps of: unoccluding the arterial line; closing or compressing a clamping mechanism engaged with the fluid delivery line; and initiating dialysis therapy.

提供了一种透析系统,包括流体源;透析管组,其至少包括动脉管线、血液泵部分和将流体源连接到透析管组的流体递送管线;血液泵,其被配置为与透析管组的血液泵部分接合;第一夹紧机构,其被配置为与动脉管线接合;第二夹紧机构,其被配置为与流体递送管线接合;以及电子控制器,该电子控制器被配置为控制血液泵、第一夹紧机构以及第二夹紧机构的操作,其中,在灌注序列期间,该电子控制器被配置为:关闭或闭塞第一夹紧机构;将第二夹紧机构打开或解除闭塞;调控血液泵的泵速以增加透析管组内的流体压力,并且将流体从流体源通过流体递送管线递送到透析管中。A dialysis system is provided, comprising a fluid source; a dialysis tubing set comprising at least an arterial line, a blood pump portion, and a fluid delivery line connecting the fluid source to the dialysis tubing set; a blood pump configured to communicate with the dialysis tubing set a blood pump partially engaged; a first clamping mechanism configured to engage the arterial line; a second clamping mechanism configured to engage the fluid delivery line; and an electronic controller configured to control the blood operation of the pump, the first clamping mechanism, and the second clamping mechanism, wherein, during the priming sequence, the electronic controller is configured to: close or occlude the first clamping mechanism; open or unocclude the second clamping mechanism ; regulating the pump speed of the blood pump to increase the fluid pressure within the dialysis tubing set and delivering fluid from the fluid source through the fluid delivery line into the dialysis tubing.

在一个实施例中,电子控制器被配置为通过将血液泵的流速从第一流速增加到第二流速来调控血液泵的泵速。In one embodiment, the electronic controller is configured to regulate the pump speed of the blood pump by increasing the flow rate of the blood pump from the first flow rate to the second flow rate.

在另一实施例中,电子控制器被配置为通过将血液泵的流速从第一流速降低到第二流速来调控血液泵的泵速。In another embodiment, the electronic controller is configured to regulate the pump speed of the blood pump by decreasing the flow rate of the blood pump from the first flow rate to the second flow rate.

在一些示例中,电子控制器被配置为通过使血液泵的流速脉冲化来调控血液泵的泵速。In some examples, the electronic controller is configured to regulate the pump speed of the blood pump by pulsing the flow rate of the blood pump.

在一个实施例中,电子控制器被配置为调控血液泵的泵速,包括将血液泵的流速从大约320ml/min降低到大约180ml/min。In one embodiment, the electronic controller is configured to regulate the pump rate of the blood pump, including reducing the flow rate of the blood pump from about 320 ml/min to about 180 ml/min.

在另一实施例中,控制器被配置为在透析治疗期间周期性地自动执行关闭步骤、打开步骤和调控步骤。In another embodiment, the controller is configured to automatically perform the closing step, opening step and regulating step periodically during the dialysis treatment.

在一些实施例中,在打开或释放夹紧机构之后,由于流体递送管线的前延长夹紧,流体递送管线的一部分保持闭塞。In some embodiments, a portion of the fluid delivery line remains occluded due to the clamping of the forward extension of the fluid delivery line after the clamping mechanism is opened or released.

在一个实施例中,在打开或释放夹紧机构之后,由于流体递送管线的前延长夹紧,流体递送管线的一部分保持部分地闭塞。In one embodiment, after opening or releasing the clamping mechanism, a portion of the fluid delivery line remains partially occluded due to the clamping of the forward extension of the fluid delivery line.

在一些实施例中,电子控制器还被配置为:将动脉管线解除闭塞;关闭或压缩与流体递送管线接合的夹紧机构;以及启动透析治疗。In some embodiments, the electronic controller is further configured to: unocclude the arterial line; close or compress a pinch mechanism engaged with the fluid delivery line; and initiate dialysis treatment.

提供了一种在透析治疗期间提高透析器的性能的方法,包括以下步骤:启动透析治疗;检测透析器的血液侧与透析器的透析液侧之间的压力差;如果压力差超过预定阈值,则:闭塞透析管的动脉管线;打开或释放与流体递送管线接合的夹紧机构;调控与透析管接合的血液泵的泵速,以增加透析管内的流体压力;以及,将流体从流体源通过流体递送管线递送到透析管中。A method of increasing the performance of a dialyzer during a dialysis treatment is provided, comprising the steps of: initiating the dialysis treatment; detecting a pressure difference between a blood side of the dialyzer and a dialysate side of the dialyzer; if the pressure difference exceeds a predetermined threshold, Then: occlude the arterial line of the dialysis tubing; open or release the clamping mechanism engaged with the fluid delivery line; regulate the pump speed of the blood pump engaged with the dialysis tubing to increase the fluid pressure in the dialysis tubing; and, pass the fluid from the fluid source through the A fluid delivery line delivers into the dialysis tubing.

在一些实施例中,调控血液泵的泵速包括将血液泵的流速从第一流速增加到第二流速。In some embodiments, modulating the pump speed of the blood pump includes increasing the flow rate of the blood pump from a first flow rate to a second flow rate.

在其他实施例中,调控血液泵的泵速包括将血液泵的流速从第一流速降低到第二流速。In other embodiments, modulating the pump speed of the blood pump includes decreasing the flow rate of the blood pump from the first flow rate to the second flow rate.

在一个实施例中,调控血液泵的泵速包括使血液泵的流速脉冲化。In one embodiment, modulating the pump speed of the blood pump includes pulsating the flow rate of the blood pump.

提供了一种在使用透析系统进行透析治疗之后将血液返回给患者的方法,该透析系统包括将流体接受器(fluid receptacle)连接到透析管组的流体递送管线,该方法包括以下步骤:打开或释放与流体递送管线接合的夹紧机构;使透析液反过滤(backfiltering)通过透析系统的透析器,进入透析管组,并且经由流体递送管线进入流体接受器中;用透析系统执行透析治疗,包括将血液抽吸到透析管组中;以及用流体接受器中的反过滤的透析液将血液返回给患者。A method of returning blood to a patient following dialysis treatment using a dialysis system comprising a fluid delivery line connecting a fluid receptacle to a dialysis tubing set comprises the steps of: opening or releasing the clamping mechanism engaged with the fluid delivery line; backfiltering the dialysate through the dialyzer of the dialysis system, into the dialysis tubing set, and into the fluid receiver via the fluid delivery line; performing dialysis therapy with the dialysis system, comprising drawing blood into the dialysis tubing set; and returning the blood to the patient with back-filtered dialysate in the fluid receiver.

在一些实施例中,使透析液反过滤通过透析器还包括控制位于透析器上游的第一透析液泵以具有比位于透析器下游的第二透析液泵更快的泵速。In some embodiments, backfiltering the dialysate through the dialyzer further includes controlling a first dialysate pump upstream of the dialyzer to have a faster pump speed than a second dialysate pump downstream of the dialyzer.

附图简述Brief description of the drawings

特别地,本发明的新颖特征在所附权利要求中具体地阐述。通过参考以下详细描述和附图将获得对本发明的特征和优点的更好理解,该详细描述阐述了利用了本发明的原理的说明性实施例,在附图中:The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by referring to the following detailed description, which sets forth illustrative embodiments that utilize the principles of the invention, and the accompanying drawings, in which:

图1示出了透析系统的一个实施例。Figure 1 shows an embodiment of a dialysis system.

图2示出了透析系统的水净化系统的一个实施例。Figure 2 shows an embodiment of a water purification system of a dialysis system.

图3示出了透析系统的透析递送系统的一个实施例。Figure 3 illustrates one embodiment of a dialysis delivery system of a dialysis system.

图4示出了生理盐水源、血液回路与患者之间的连接。Figure 4 shows the connection between the saline source, the blood circuit and the patient.

图5A示出了用透析系统递送生理盐水的方法。Figure 5A shows a method of delivering saline with a dialysis system.

图5B是示出生理盐水递送期间血液泵流速和动脉管线压力的曲线图。Figure 5B is a graph showing blood pump flow rate and arterial line pressure during saline delivery.

图6A示出了用透析系统递送生理盐水的方法。Figure 6A shows a method of delivering saline with a dialysis system.

图6B是示出生理盐水递送期间血液泵流速和动脉管线压力的曲线图。6B is a graph showing blood pump flow rate and arterial line pressure during saline delivery.

图7和图8示出了用透析系统递送生理盐水的方法。7 and 8 illustrate methods of delivering saline with a dialysis system.

图9A-图9B是具有反冲配置(rinseback configuration)的透析系统的一个实施例的示意图。9A-9B are schematic diagrams of one embodiment of a dialysis system with a rinseback configuration.

图10是在透析治疗后使用反过滤的透析液将血液返回给患者的方法和流程图。Figure 10 is a method and flowchart of returning blood to a patient using back-filtered dialysate after dialysis treatment.

详细描述A detailed description

本公开描述了与透析治疗相关的系统、装置和方法,包括易于使用并且包括自动化特征的透析系统,该自动化特征消除或减少了透析治疗期间对技术人员参与的需要。在一些实施例中,透析系统可以是家庭透析系统。透析系统的实施例可以包括自动化和提高透析治疗的性能、效率和安全性的各种特征。The present disclosure describes systems, devices, and methods related to dialysis treatment, including dialysis systems that are easy to use and include automation features that eliminate or reduce the need for technician involvement during dialysis treatment. In some embodiments, the dialysis system may be a home dialysis system. Embodiments of dialysis systems may include various features to automate and improve the performance, efficiency, and safety of dialysis treatments.

在一些实施例中,描述了可以向用户提供急性和慢性透析治疗的透析系统。该系统可以包括水净化系统以及透析递送系统,该水净化系统被配置为使用可用水源实时制备用于透析治疗的水,该透析递送系统被配置为制备用于透析治疗的透析液。透析系统可以包括一次性盒(cartridge)和管组,用于在透析治疗期间连接到用户,以从用户处获取和递送血液。In some embodiments, a dialysis system is described that can provide acute and chronic dialysis treatment to a user. The system may include a water purification system configured to prepare water for dialysis treatment in real time using an available water source, and a dialysis delivery system configured to prepare dialysate for dialysis treatment. A dialysis system may include a disposable cartridge and tubing set for connection to a user during a dialysis treatment for obtaining and delivering blood from the user.

图1示出了透析系统100的一个实施例,该透析系统100被配置为在临床或非临床环境(例如用户的家中)中向用户提供透析治疗。透析系统100可以包括设置在壳体106内的水净化系统102和透析递送系统104。水净化系统102可以被配置为实时净化水源以用于透析治疗。例如,水净化系统可以连接到住宅水源(例如自来水)并且实时制备巴氏杀菌后的水。然后,巴氏杀菌后的水可以用于透析治疗(例如,与透析递送系统一起),而不需要加热和冷却通常与水净化方法相关的大批量水。FIG. 1 illustrates one embodiment of a dialysis system 100 configured to provide dialysis treatment to a user in a clinical or non-clinical setting, such as the user's home. Dialysis system 100 may include water purification system 102 and dialysis delivery system 104 disposed within housing 106 . Water purification system 102 may be configured to purify a water source in real time for dialysis treatment. For example, a water purification system can be connected to a residential water source (eg, tap water) and prepare pasteurized water in real time. The pasteurized water can then be used in dialysis treatment (eg, with a dialysis delivery system) without the need for heating and cooling of the bulk water typically associated with water purification methods.

透析系统100还可以包括盒和/或管组120,该盒和/或管组120可以可拆卸地联接到系统的壳体106。盒可以包括附接到管理器的患者管组,这将在下面更详细地描述。盒和管组(可以是无菌的、用后即丢弃的、一次性使用的部件)被配置成在治疗前连接到透析系统。在透析治疗之前,这种连接使盒、管组与透析系统之间的相应部件正确地对准。例如,当盒联接到透析系统时,管组自动与一个或更多个泵(例如,蠕动泵)、夹具和传感器相关联,用于抽取和泵送用户的血液通过管组。管组还可以与透析系统的生理盐水源相关联,用于在治疗前自动灌注和空气去除。在一些实施例中,生理盐水源可以是用于透析治疗的任何通用置换流体(包括但不限于生理盐水、无菌等渗流体、血液、供体血浆等)的源。在一些实施例中,盒和管组可以连接到透析系统的透析器126。在其他实施例中,盒和管组可以包括预先附接到管组的内置透析器。用户或患者可以经由包括显示器的用户界面113与透析系统交互。Dialysis system 100 may also include a cassette and/or tubing set 120 that may be detachably coupled to housing 106 of the system. The cassette may include a patient tubing set attached to a manager, which will be described in more detail below. The cassette and tubing set (which may be a sterile, disposable, single-use component) is configured for connection to the dialysis system prior to treatment. This connection enables proper alignment of the cassette, tubing set and corresponding components between the dialysis system prior to dialysis treatment. For example, when the cassette is coupled to the dialysis system, the tubing set is automatically associated with one or more pumps (eg, peristaltic pumps), clamps, and sensors for drawing and pumping the user's blood through the tubing set. The tubing set can also be associated with the dialysis system's saline source for automatic perfusion and air removal prior to treatment. In some embodiments, the saline source can be any source of replacement fluid commonly used in dialysis treatment, including but not limited to saline, sterile isotonic fluid, blood, donor plasma, and the like. In some embodiments, the cassette and tubing set can be connected to the dialyzer 126 of the dialysis system. In other embodiments, the cassette and tubing set may include a built-in dialyzer pre-attached to the tubing set. A user or patient can interact with the dialysis system via a user interface 113 that includes a display.

图2-图3分别地示出了透析系统100的一个实施例的水净化系统102和透析递送系统104。为了便于解释,分开示出和描述了这两个系统,但是应当理解,这两个系统可以都被包括在透析系统的单个壳体106中。图2示出了包含在壳体106内的水净化系统102的一个实施例,壳体106可以包括前门105(示出为处于打开位置)。前门105可以提供对与水净化系统相关联的特征(例如一个或更多个过滤器,包括沉淀物过滤器108、碳过滤器110和反渗透(RO)过滤器112)的接近。过滤器可以被配置为辅助净化来自与水净化系统102流体连通的水源(例如自来水)的水。水净化系统还可以包括加热元件和冷却元件(包括热交换器),这些加热元件和冷却元件被配置为进行巴氏杀菌并控制系统中的流体温度,如下文将更详细地描述的。该系统可以选择性地包括氯样品端口195,以提供流体的样品用于测量氯含量。2-3 illustrate a water purification system 102 and a dialysis delivery system 104 of one embodiment of a dialysis system 100, respectively. For ease of explanation, the two systems are shown and described separately, but it should be understood that both systems may be included in a single housing 106 of the dialysis system. Figure 2 illustrates one embodiment of a water purification system 102 contained within a housing 106, which may include a front door 105 (shown in an open position). Front door 105 may provide access to features associated with the water purification system, such as one or more filters, including sediment filter 108 , carbon filter 110 , and reverse osmosis (RO) filter 112 . The filter may be configured to assist in the purification of water from a water source (eg, tap water) in fluid communication with the water purification system 102 . The water purification system may also include heating and cooling elements (including heat exchangers) configured to pasteurize and control the temperature of fluid in the system, as will be described in more detail below. The system may optionally include a chlorine sample port 195 to provide a sample of the fluid for measuring chlorine levels.

在图3中,包含在壳体106内的透析递送系统104可以包括上盖109和前门111,上盖109和前门111两者都示出为处于打开位置。上盖109可以打开以允许访问透析系统的各种特征,例如用户界面113(例如,计算装置,包括电子控制器和诸如触摸屏的显示器)和透析液容器117。前门111可以打开和关闭以允许接近前面板210,前面板210可以包括被配置为与盒120及盒相关联的管组相互作用的各种特征,包括被配置为将盒120联接到透析系统100的对准特征和附接特征。透析器126可以安装在前门111中或前面板上,并且可以包括将透析器连接到制备的透析液以及连接到盒的管组的管线或端口。In FIG. 3 , dialysis delivery system 104 contained within housing 106 may include upper cover 109 and front door 111 , both of which are shown in an open position. Upper cover 109 can be opened to allow access to various features of the dialysis system, such as user interface 113 (eg, a computing device including electronic controls and a display such as a touch screen) and dialysate container 117 . Front door 111 can be opened and closed to allow access to front panel 210, which can include various features configured to interact with cassette 120 and its associated tubing set, including being configured to couple cassette 120 to dialysis system 100. alignment and attachment features. The dialyzer 126 may be mounted in the front door 111 or on the front panel and may include lines or ports connecting the dialyzer to the prepared dialysate and to the tubing set of the cassette.

在一些实施例中,透析系统100还可以包括血压袖带,以提供对用户血压的实时监测。该系统(即,该系统的电子控制器)可以被配置为在透析治疗期间监测用户的血压。如果用户的血压下降到阈值以下(例如,指示用户低渗的血压阈值),则系统可以用低血压警报警告用户,并且透析治疗可以停止。在用户忽略来自系统的可配置数量的低血压警报的情况下,系统可以被配置为自动停止透析治疗,此时系统可以通知用户需要将用户的血液(残留在管组和透析器中的血液)返回到用户的身体。例如,系统可以被预编程为如果用户忽略三个低血压警报则自动停止治疗。在其他实施例中,该系统可以在恢复透析治疗之前给予用户大剂量的生理盐水以使用户液位恢复。在去除超滤流体期间,可以跟踪和计算递送给患者的生理盐水的量。In some embodiments, the dialysis system 100 may also include a blood pressure cuff to provide real-time monitoring of the user's blood pressure. The system (ie, the electronic controller of the system) can be configured to monitor a user's blood pressure during dialysis treatment. If the user's blood pressure drops below a threshold (eg, a blood pressure threshold indicating hypotonicity for the user), the system can alert the user with a low blood pressure alert, and dialysis treatment can be stopped. In the event the user ignores a configurable number of low blood pressure alerts from the system, the system can be configured to automatically stop dialysis treatment, at which point the system can notify the user that the user's blood (blood remaining in the tubing set and dialyzer) needs to be removed Return to the user's body. For example, the system can be preprogrammed to automatically stop therapy if the user ignores three low blood pressure alerts. In other embodiments, the system may administer a bolus of saline to the user to restore the user's fluid level before resuming dialysis treatment. During removal of ultrafiltered fluid, the amount of saline delivered to the patient can be tracked and calculated.

图3的透析递送系统104可以被配置为用由图2的水净化系统102供应的净化水自动制备透析液流体。此外,透析递送系统可以使净化后的水脱气,并在来自透析液容器117的酸和碳酸氢盐浓缩物中进行配比和混合。所得到的透析液流体可以通过一个或更多个超滤器(如下所述)以确保透析液流体满足微生物和内毒素污染物的某些监管限制。The dialysis delivery system 104 of FIG. 3 may be configured to automatically prepare dialysate fluid from purified water supplied by the water purification system 102 of FIG. 2 . In addition, the dialysis delivery system may degas the purified water, proportioned and mixed in the acid and bicarbonate concentrate from the dialysate container 117 . The resulting dialysate fluid can be passed through one or more ultrafilters (described below) to ensure that the dialysate fluid meets certain regulatory limits for microbial and endotoxin contaminants.

通过使用户的血液和透析液经过透析器126,可以在透析系统100的透析递送系统104中执行透析。透析系统100可以包括电子控制器,该电子控制器被配置为管理用于调节透析液和血液流入和流出透析器的流量的各种流量控制装置和特征,以便实现不同类型的透析,包括血液透析、超滤和血液透析过滤。Dialysis may be performed in dialysis delivery system 104 of dialysis system 100 by passing a user's blood and dialysate through dialyzer 126 . Dialysis system 100 may include an electronic controller configured to manage various flow control devices and features for regulating the flow of dialysate and blood into and out of the dialyzer in order to achieve different types of dialysis, including hemodialysis , ultrafiltration and hemodiafiltration.

透析系统可以包括生理盐水源或其他血液相容性流体与体外血液回路之间的连接。这种流体可以用于许多应用,例如在治疗前灌注回路,递送大剂量(bolus)以提高血液动力学稳定性,递送周期性冲洗以减轻回路凝血,置换流体以实现高对流治疗,以及当血液在治疗结束时返回时的追逐流体(chaser fluid)。典型地,这种生理盐水源可以是袋,该袋被附接到分支管线的尖头(spike)穿透,该分支管线通入体外血液回路。来自生理盐水源的流动可以通过夹紧和松开物理夹具或电子控制夹管阀来控制。通入处于负压的血液回路的一部分(例如回路中的血液泵的上游)是有利的,使得当管线松开时,负压将促进来自生理盐水源的流动。A dialysis system may include a connection between a saline source or other hemocompatible fluid and an extracorporeal blood circuit. This fluid can be used in many applications such as perfusing the circuit prior to therapy, delivering bolus to improve hemodynamic stability, delivering periodic flushes to alleviate circuit coagulation, replacing fluid for high convective therapy, and when blood Chaser fluid when returning at the end of treatment. Typically, such a saline source may be a bag pierced by a spike attached to a branch line leading into the extracorporeal blood circuit. Flow from a saline source can be controlled by pinching and loosening a physical clamp or an electronically controlled pinch valve. Access to a part of the blood circuit that is under negative pressure (for example upstream of a blood pump in the circuit) is advantageous so that when the line is released, the negative pressure will facilitate flow from the saline source.

本公开提供了被配置为精确且准确地计量来自生理盐水源的流体的流量的方法和系统。在一种配置中,参考图4,透析系统(例如上述系统100)可以包括生理盐水源401,该生理盐水源401被配置为在血液泵403的上游连接到管组420。如图所示,透析器426也可以连接到管组。管组420可以包括生理盐水管线405、动脉管线407和静脉管线409。管组可以被配置成与一个或更多个夹紧夹具(例如生理盐水夹具411(也称为“泵前生理盐水夹管阀”)和动脉夹具413(也称为“动脉夹管阀”))接合。应当理解,也可以使用其他机构来关闭/闭塞管组和使管组打开/解除闭塞。通常,这里提到的夹具或夹管阀包括与管组接合以打开或关闭通过管组的流体流动的任何机构。The present disclosure provides methods and systems configured to precisely and accurately meter the flow of fluid from a saline source. In one configuration, referring to FIG. 4 , a dialysis system such as the system 100 described above may include a saline source 401 configured to connect to a tubing set 420 upstream of a blood pump 403 . As shown, a dialyzer 426 may also be connected to the tubing set. Tubing set 420 may include saline line 405 , arterial line 407 and venous line 409 . The tubing set can be configured with one or more pinch clamps such as saline clamp 411 (also known as "pre-pump saline pinch valve") and arterial clamp 413 (also known as "arterial pinch valve") ) engagement. It should be understood that other mechanisms may be used to close/occlude and open/unocclude the tube stack. Generally, clamps or pinch valves as referred to herein include any mechanism that engages a tubing stack to open or close fluid flow through the tubing stack.

在一个实施例中,生理盐水夹具411可以被控制为被松开(例如,泵前生理盐水夹管阀被打开),并且血液泵可以被配置为以正常操作模式运行或操作。尽管血液泵的总输出是已知的,但血液泵从患者处抽吸其流量的不确定部分,并且从生理盐水源处抽吸其流量的第二不确定部分。一种用于计量抽吸到管组中的生理盐水量的技术是同时闭塞从患者引出的动脉管线(用动脉夹具413)并且使生理盐水管线解除闭塞以递送生理盐水(通过打开生理盐水夹具411)。例如,夹管阀可以由计算机控制,因此可以利用系统的电子控制器来实现夹具511和413的打开和/或关闭。通过这样做,血液泵的全部输入和输出从患者切换到生理盐水源,以允许精确计量递送的生理盐水。在治疗期间的正常操作中,动脉夹具打开以允许流动,并且生理盐水夹具关闭以防止生理盐水进入回路。In one embodiment, the saline clamp 411 can be controlled to be loosened (eg, the pre-pump saline pinch valve is opened), and the blood pump can be configured to run or operate in a normal operating mode. Although the total output of the blood pump is known, the blood pump draws an indeterminate portion of its flow from the patient and a second indeterminate portion of its flow from the saline source. One technique for metering the amount of saline drawn into the tubing set is to simultaneously occlude the arterial line emerging from the patient (with the arterial clamp 413) and unocclude the saline line to deliver saline (by opening the saline clamp 411 ). For example, the pinch valve can be computer controlled, so the opening and/or closing of clamps 511 and 413 can be effected using the system's electronic controller. By doing so, the overall input and output of the blood pump is switched from the patient to the saline source, allowing accurate metering of the saline delivered. In normal operation during therapy, the arterial clamp is open to allow flow and the saline clamp is closed to prevent saline from entering the circuit.

包括血液回路管组的管通常由聚合物构成,随着时间的推移,特别是在负载下,该聚合物表现出性质变化。在大部分治疗中生理盐水管线管在高的力下保持闭塞的性能在较长时间的治疗中变得更加重要。典型的间歇性血液透析(intermittent hemodialysis,IHD)治疗可能持续四个小时;然而,部分间歇性肾脏替代疗法(partial intermittentrenal replacement therapy,PIRRT)、缓慢低效透析(slow,low-efficiency dialysis,SLED)和连续肾脏替代疗法(continuous renal replacement therapy,CRRT)治疗可能持续24小时或更长时间。当管组被压缩力保持在闭塞状态时,管组可能产生压缩形变,或者表现出应力松弛行为。当压缩力被去除以使管解除闭塞时,材料特性变化的程度可能影响管打开所需的时间,或者管是否完全打开。如果前一闭塞点的一侧处于负压下(例如血液泵的上游),这种情况会加剧,这会趋向于促使管的壁保持彼此封闭。Tubing, including blood circuit tubing sets, is usually composed of polymers which exhibit changes in properties over time, especially under load. The ability of saline line tubing to maintain occlusion under high forces during most treatments becomes more important during longer periods of treatment. Typical intermittent hemodialysis (IHD) treatment may last four hours; however, partial intermittent renal replacement therapy (PIRRT), slow, low-efficiency dialysis (SLED) and continuous renal replacement therapy (CRRT) treatment may last 24 hours or longer. When the tube stack is held in an occluded state by a compressive force, the tube stack may undergo compression deformation, or exhibit stress relaxation behavior. When the compressive force is removed to unocclude the tube, the degree to which the material properties change may affect the time it takes for the tube to open, or whether the tube opens completely. This situation is exacerbated if one side of the previous occlusion point is under negative pressure (for example upstream of a blood pump), which will tend to force the walls of the tube to remain closed to each other.

如果尽管消除了压缩力(例如,通过打开夹管阀),生理盐水管线仍然保持闭塞,则没有生理盐水可以流动。如果当试图打开生理盐水管时,动脉管保持解除闭塞,则不递送生理盐水。如果在试图打开生理盐水管线时动脉管线被闭塞,那么当泵试图对两条闭塞的管线抽吸时,会产生非常低的负压。这种情况可以被机器检测到,这可能导致不必要的警报,从而中断工作流程或终止治疗。If the saline line remains occluded despite removal of the compressive force (eg, by opening the pinch valve), no saline can flow. If the arterial line remains unoccluded when an attempt is made to open the saline line, no saline is delivered. If the arterial line is occluded when trying to open the saline line, a very low negative pressure will be generated as the pump tries to pump through both occluded lines. This condition can be detected by the machine, which can lead to unnecessary alerts that interrupt workflow or terminate treatment.

在图5A和图5B中分别提供了已经闭塞16小时的管的动脉压的过程流程图和示例性曲线,示出了急剧向下的尖峰。例如,参考图5A,一种方法包括在步骤502接收“递送生理盐水”命令,该命令启动关闭动脉夹管阀并打开泵前生理盐水夹管阀。在步骤504和506,动脉夹管阀可以关闭并且泵前生理盐水夹管阀可以打开。接下来,在步骤508,生理盐水经由血液泵被递送到血液回路中。当期望体积的生理盐水已经被抽吸到血液回路中时,动脉夹管阀可以在步骤510打开,并且泵前生理盐水夹管阀可以在步骤512关闭。最后,在步骤514恢复正常治疗。A process flow diagram and exemplary curves of arterial pressure for a tube that has been occluded for 16 hours, showing a sharp downward spike, are provided in FIGS. 5A and 5B , respectively. For example, referring to FIG. 5A , a method includes receiving a "deliver saline" command at step 502 , which initiates closing of the arterial pinch valve and opening of the pre-pump saline pinch valve. At steps 504 and 506, the arterial pinch valve may be closed and the pre-pump saline pinch valve may be opened. Next, at step 508, saline is delivered into the blood circuit via the blood pump. When the desired volume of saline has been drawn into the blood circuit, the arterial pinch valve may be opened at step 510 and the pre-pump saline pinch valve may be closed at step 512 . Finally, normal treatment resumes at step 514 .

为了提高长时间闭塞的管的性能,本文引入了一种新的步骤,其中在生理盐水阀打开并且动脉夹管阀关闭之后,引入了临时调控血液泵的步骤。该调控可以包括减慢、停止、反转或脉冲化血液泵。通过这样做,流经血液管线的流体的动能必然会被阻止或吸收,以造成流动停止。这就产生了“水锤(water hammer)”效应,导致压力急剧上升。这种压力的上升传播到生理盐水管线中的闭塞点,这有助于迫使闭塞点打开。在图6A-图6B中提供了改进的流程图和示例性压力曲线。参考图6A,本公开的新颖性方法包括在步骤602接收“递送生理盐水”命令,该命令在步骤604启动关闭动脉夹管阀并在步骤606启动打开泵前生理盐水夹管阀。接下来,在步骤607,改变血液泵速(例如,从“正常”操作速度增加或减少血液泵速,或者可替代地调控或脉冲化血液泵速)。接下来,在步骤608,生理盐水经由血液泵被递送到血液回路中。当期望体积的生理盐水已经被抽吸到血液回路中时,动脉夹管阀可以在步骤610打开,并且泵前生理盐水夹管阀可以在步骤612关闭。最后,在步骤614恢复正常治疗。改变血液泵速可以包括,例如,将血液泵速从第一流速(例如,320ml/min)暂时减慢到第二流速(例如,180ml/min)。这消除了图5B所示的向下的尖峰,而是引入了动脉压的向上的尖峰。在其他实施例中,血液泵速可以被暂时增加到第一流速与第二流速之间。如上所述,在一些实施例中,在该步骤中,血液泵的速度可以被快速改变或“脉冲化”。In order to improve the performance of long-term occluded tubes, a new procedure is introduced in which a temporary modulation of the blood pump is introduced after the saline valve is opened and the arterial pinch valve is closed. This regulation may include slowing, stopping, reversing or pulsing the blood pump. By doing so, the kinetic energy of the fluid flowing through the blood line must be arrested or absorbed, causing the flow to stop. This creates a "water hammer" effect, causing a dramatic rise in pressure. This rise in pressure propagates to the occlusion in the saline line, which helps force the occlusion open. An improved flowchart and exemplary pressure curves are provided in FIGS. 6A-6B . Referring to FIG. 6A , the novel method of the present disclosure includes receiving a “deliver saline” command at step 602 , which initiates closing of the arterial pinch valve at step 604 and opening of the pre-pump saline pinch valve at step 606 . Next, at step 607, the blood pump rate is varied (eg, increased or decreased from a "normal" operating rate, or alternatively modulated or pulsed). Next, at step 608, saline is delivered into the blood circuit via the blood pump. When the desired volume of saline has been drawn into the blood circuit, the arterial pinch valve may be opened at step 610 and the pre-pump saline pinch valve may be closed at step 612 . Finally, normal treatment resumes at step 614 . Changing the blood pump rate may include, for example, temporarily slowing the blood pump rate from a first flow rate (eg, 320ml/min) to a second flow rate (eg, 180ml/min). This eliminates the downward spike shown in Figure 5B and instead introduces an upward spike in arterial pressure. In other embodiments, the blood pump rate may be temporarily increased between the first flow rate and the second flow rate. As noted above, in some embodiments, the speed of the blood pump may be rapidly varied or "pulsed" during this step.

本公开的相关方面是自动调度生理盐水递送冲洗的能力。参考图7的流程图,在步骤702,透析系统的用户可以首先为患者设置净期望流体去除速率或目标。接下来,在步骤704,用户可以指定期望的生理盐水冲洗间隔和要递送的生理盐水体积、以及期望的治疗持续时间(步骤706),并且可以在步骤708启动治疗。在治疗期间,图6A的冲洗过程将周期性地发生。这可以有助于减轻回路凝血,允许更高的流体去除以增强对流清除,或者用作稀释指示器以执行生理测量(例如血容量、通路再循环或通路流量)。例如,仍然参考图7,在步骤710,系统可以检查步骤706的治疗持续时间是否已经过去。如果否,则在步骤712,系统将检查步骤704的冲洗间隔是否已经过去。当该间隔过去时,作为步骤714,系统可以使用图6A所示的方法将生理盐水递送到管组中。在步骤716,系统可以增加超滤以从治疗中去除来自步骤714的生理盐水冲洗,并维持净流体去除目标。A related aspect of the present disclosure is the ability to automatically schedule saline delivery flushes. Referring to the flowchart of FIG. 7, at step 702, a user of the dialysis system may first set a net desired fluid removal rate or target for the patient. Next, at step 704 , the user may specify a desired saline flush interval and volume of saline to be delivered, as well as a desired duration of therapy (step 706 ), and therapy may be initiated at step 708 . During treatment, the flushing process of Figure 6A will occur periodically. This can help alleviate circuit coagulation, allow higher fluid removal to enhance convective clearance, or be used as a dilution indicator to perform physiological measurements (such as blood volume, access recirculation, or access flow). For example, still referring to FIG. 7, at step 710, the system may check whether the treatment duration of step 706 has elapsed. If not, then at step 712 the system will check whether the flush interval of step 704 has elapsed. When the interval elapses, the system may deliver saline into the tubing set as step 714 using the method shown in FIG. 6A. At step 716, the system may add ultrafiltration to remove the saline flush from step 714 from the treatment and maintain a net fluid removal target.

用户还可以在治疗结束之前设置期望的间隔,此时没有生理盐水冲洗发生。如果已知生理盐水冲洗的期望频率和体积,以及预期的治疗时间,则可以计算出所需的总生理盐水。假设每个生理盐水容器(例如1升生理盐水袋)具有已知的体积,则该系统将能够在治疗之前通知用户收集所需数量的生理盐水容器以完成所需的生理盐水冲洗节奏。可替代地,系统可以显示所需的总生理盐水体积,用户可以将所需的总生理盐水体积以单个或多个较大的容器来提供。该系统可以进一步确定将要使用的最后一个生理盐水容器中的未使用的体积(减去血液回流(Blood return)所需的体积),并建议增加体积和/或频率,使得该未使用的体积用于额外的冲洗而不被浪费。可替代地,总的流体去除目标可以有效地增加接近所述未使用体积的体积,超过流体去除目标。在治疗结束时,该系统然后可以注入未使用的体积以实现最初的流体去除目标。Users can also set a desired interval before the end of treatment when no saline flush occurs. If the desired frequency and volume of saline flushes are known, as well as the expected duration of treatment, the total saline required can be calculated. Assuming each saline container (eg, 1 liter saline bag) has a known volume, the system will be able to notify the user prior to treatment to collect the required number of saline containers to complete the desired saline flush cadence. Alternatively, the system may display the total saline volume required, which the user may provide in a single or multiple larger containers. The system can further determine the unused volume in the last saline container to be used (minus the volume required for blood return) and recommend increasing the volume and/or frequency such that the unused volume is used for extra flushing without being wasted. Alternatively, the total fluid removal target may effectively increase the volume close to the unused volume beyond the fluid removal target. At the end of treatment, the system can then inject the unused volume to achieve the initial fluid removal goal.

仍然参考图7,在步骤716,透析系统还可以配置成自动增加患者的流体去除速率,以便随着时间的推移去除由这些生理盐水冲洗添加的额外流体。简单地说,这可以被调节为仅仅去除由生理盐水冲洗产生的过多的体积,以便实现期望的净流体去除目标。这减少了用户计算注入的生理盐水量并手动调节流体去除量以解决这一问题的精神负担。由生理盐水冲洗引起的总血容量的稀释也可用于执行可用血容量的测量。也可以基于该测量来调节流体去除速率。Still referring to FIG. 7 , at step 716 the dialysis system can also be configured to automatically increase the patient's fluid removal rate in order to remove the additional fluid added by these saline flushes over time. Briefly, this can be adjusted to remove only the excess volume created by the saline flush in order to achieve the desired net fluid removal target. This reduces the mental burden on the user of calculating the amount of saline to infuse and manually adjusting the amount of fluid removal to account for this. Dilution of total blood volume caused by saline irrigation can also be used to perform measurements of available blood volume. The fluid removal rate can also be adjusted based on this measurement.

在另一实施例中,参考图8的流程图,冲洗间隔不是预定的,而是基于各种参数的测量结果触发的。参考图8的流程图,在步骤802,透析系统的用户可以首先为患者设置净期望流体去除速率或目标。接下来,在步骤804,用户可以指定期望的生理盐水冲洗间隔和要递送的生理盐水体积、以及期望的治疗持续时间(步骤806),并且可以在步骤808启动治疗。例如,仍然参考图8,在步骤810,系统可以检查步骤806的治疗持续时间是否已经过去。如果否,则在步骤812,系统可以测量与透析系统、透析器或透析治疗相关联的参数。在一个实施例中,参数可以包括跨膜压力。例如,跨膜压力定义为透析器的透析液侧与透析器的血液侧的压力差。如果透析器内发生凝血,则两个隔室之间的流动阻力增加,并且因此跨膜压力增加。对于高通量透析器,即使在高的超滤速率下,通常也有非常低的跨膜压力,除非有某种程度的凝血。如果在步骤814检测到跨膜压力满足某个阈值,则透析系统可以在步骤816自动启动生理盐水冲洗。在步骤818,如上讨论的,可以增加超滤以在治疗期间去除冲洗体积并保持净流体去除目标。In another embodiment, referring to the flowchart of FIG. 8, the flushing interval is not predetermined, but triggered based on measurements of various parameters. Referring to the flowchart of FIG. 8, at step 802, a user of the dialysis system may first set a net desired fluid removal rate or target for the patient. Next, at step 804 , the user may specify a desired saline flush interval and volume of saline to be delivered, as well as a desired duration of therapy (step 806 ), and therapy may be initiated at step 808 . For example, still referring to FIG. 8, at step 810, the system may check whether the treatment duration of step 806 has elapsed. If not, then at step 812 the system can measure parameters associated with the dialysis system, dialyzer, or dialysis treatment. In one embodiment, the parameters may include transmembrane pressure. For example, transmembrane pressure is defined as the pressure difference between the dialysate side of the dialyzer and the blood side of the dialyzer. If coagulation occurs within the dialyzer, the resistance to flow between the two compartments increases and thus the transmembrane pressure increases. For high-flux dialyzers, even at high ultrafiltration rates, there is usually very low transmembrane pressure unless there is some degree of coagulation. If at step 814 it is detected that the transmembrane pressure meets a certain threshold, the dialysis system may automatically initiate a saline flush at step 816 . At step 818, as discussed above, ultrafiltration may be added to remove flush volume during treatment and maintain a net fluid removal target.

可以测量或考虑其他参数(例如跨膜压力曲线的斜率),这些参数还可以用于调控因素,例如生理盐水冲洗体积或递送流动速率。这些也可以由用户调控。可以考虑其他测量,例如可以周期性地释放相对小体积的“侦察(scout)”冲洗,以便测量稀释物在透析器前后设置在回路中的两个传感器之间的传输时间。如果检测到透析器内凝血,则纤维内的体积减少,这导致相对于更早进行的基线测量,或者当没有凝血时,稀释物的传输时间减少。据报道,凝血级联还会引起血液电导率的变化。这些信号也可以用于触发生理盐水冲洗。可替代地,当达到任何这样的测量阈值时,系统可以通知用户并推荐生理盐水冲洗,这必须由用户确认,而不是自动触发生理盐水冲洗。Other parameters such as the slope of the transmembrane pressure curve can be measured or taken into account, which can also be used to regulate factors such as saline flush volume or delivery flow rate. These can also be regulated by the user. Other measurements could be considered, for example a relatively small volume of "scout" flush could be released periodically in order to measure the transit time of the dilution between two sensors placed in the circuit before and after the dialyzer. If intradialyzer coagulation is detected, the volume within the fiber is reduced, which results in a reduction in the transit time of the dilution relative to a baseline measurement taken earlier, or when there is no coagulation. The coagulation cascade has also been reported to cause changes in blood conductivity. These signals can also be used to trigger saline flushes. Alternatively, when any such measured threshold is reached, the system may notify the user and recommend a saline flush, which must be confirmed by the user, rather than automatically triggering a saline flush.

进一步的反馈可以被构建到这种用于生理盐水冲洗控制的基于测量的方法中。例如,一旦跨膜压力达到某个阈值,就可以启动生理盐水冲洗。冲洗后,再次评估跨膜压力,如果测量值仍然高于该阈值或不同的阈值,则启动另一次冲洗。这些冲洗可以重复进行,直到达到所需的跨膜压力值。该系统可以被配置为如果最大体积或冲洗次数未能将跨膜压力降低到所需体积,则通知用户。Further feedback can be built into this measurement-based approach for saline flush control. For example, a saline flush could be initiated once the transmembrane pressure reaches a certain threshold. After flushing, the transmembrane pressure is assessed again, and if the measurement is still above this threshold or a different threshold, another flush is initiated. These flushes can be repeated until the desired transmembrane pressure value is reached. The system can be configured to notify the user if the maximum volume or number of flushes fails to reduce the transmembrane pressure to the desired volume.

如本文所述,调控血液泵速率的附加步骤可以有利地帮助打开在长时间治疗期间可能已经发生压缩形变的生理盐水管线。此外,透析系统可以被配置成自动调度生理盐水冲洗,并增加流体去除速率,以解决过多的递送流体。在一些实施例中,生理盐水冲洗间隔取决于来自透析系统的测量参数(例如,测量的压力、流速、流体参数等)。As described herein, the additional step of regulating the rate of the blood pump may advantageously help open saline lines that may have undergone compression set during prolonged treatment. Additionally, the dialysis system can be configured to automatically schedule saline flushes and increase fluid removal rates to account for excess delivered fluid. In some embodiments, the saline flush interval is dependent on measured parameters from the dialysis system (eg, measured pressure, flow rate, fluid parameters, etc.).

本文描述的方法和系统提供了较少的滋扰警报和精确的生理盐水递送。此外,本文描述的方法和系统增加了用户控制回路凝血、或增加了对流清除和/或其他东西或执行生理测量的便利性,而不需要手动冲洗和调节流体去除目标。The methods and systems described herein provide less nuisance alarms and precise saline delivery. Furthermore, the methods and systems described herein increase the convenience of user control of circuit coagulation, or add convective clearance and/or other things, or perform physiological measurements without the need for manual flushing and adjustment of fluid removal targets.

对于回路凝血,目前的抗凝策略涉及全身性抗凝剂(如肝素或柠檬酸盐),如果患者不能有效代谢,这些会导致出血或严重电解质变化(钙)、代谢性碱中毒或物质积聚的风险增加。使用本文所述的调度的生理盐水冲洗克服了这一点。For circuit coagulation, current anticoagulant strategies involve systemic anticoagulants (such as heparin or citrate), which can lead to bleeding or severe electrolyte changes (calcium), metabolic alkalosis, or accumulation of substances if the patient cannot metabolize them effectively Increased risk. This was overcome using a scheduled saline flush as described herein.

出现的一个问题是在治疗期间机器出故障的情况下。假设透析液流体是实时产生的,并且与填充的生理盐水袋相比是被用于返回患者的血液的,因为流体仅“按需”产生,这样的故障可能会阻止患者的血液能够返回。其他功能(如管线的灌注和流体大剂量的递送)由于只有在机器正常工作时才需要,因此不会受到影响。因此,期望提供一种在治疗结束时使患者血液返回的装置,该装置在功能上不依赖于更广泛的机器系统是否仍然起作用,同时利用不需要生理盐水袋的后勤简单性。One problem that arises is when the machine malfunctions during treatment. Given that the dialysate fluid is generated in real time and is used to return the patient's blood in contrast to a filled saline bag, since the fluid is only generated "on demand," such a failure could prevent the patient's blood from being able to return. Other functions, such as priming of lines and delivery of fluid boluses, are not affected since they are only required when the machine is functioning normally. It would therefore be desirable to provide a device that returns the patient's blood at the end of treatment that is functionally independent of whether the wider robotic system is still functioning, while taking advantage of the logistical simplicity of not requiring saline bags.

在一种配置中,参考图9A,透析系统(例如上述系统100)可以包括反冲流体源901,该反冲流体源901被配置为在血液泵903的上游连接到管组920。如图所示,透析器926也可以连接到管组。管组920可以包括生理盐水管线905、动脉管线907和静脉管线909。管组可以被配置成与一个或更多个夹紧夹具接合,例如生理盐水夹具911(也称为“泵前生理盐水夹管阀”)和动脉夹具913(也称为“动脉夹管阀”)。In one configuration, referring to FIG. 9A , a dialysis system, such as system 100 described above, can include a backflush fluid source 901 configured to connect to tubing set 920 upstream of blood pump 903 . As shown, a dialyzer 926 may also be connected to the tubing set. Tubing set 920 may include saline line 905 , arterial line 907 and venous line 909 . The tubing set can be configured to engage with one or more pinch clamps, such as saline clamp 911 (also referred to as "pre-pump saline pinch valve") and arterial clamp 913 (also referred to as "arterial pinch valve"). ).

参照图9B,透析系统还可以包括多个透析液泵915和917,这些透析液泵915和917设置在透析器926的透析液侧上,与位于透析器的“血液侧”上的管组920相对。透析液泵中的一个可以设置在透析器的上游,并且透析液泵中的一个可以设置在透析器的下游。可以控制透析液泵的泵速,以管理通过透析器的透析液流量,并控制透析治疗期间的超滤速率。例如,为了从患者体内去除流体,下游泵915可以被控制为比上游泵917更快的泵速。Referring to FIG. 9B , the dialysis system may also include a plurality of dialysate pumps 915 and 917 disposed on the dialysate side of the dialyzer 926 with a tubing set 920 located on the "blood side" of the dialyzer. relatively. One of the dialysate pumps can be arranged upstream of the dialyzer, and one of the dialysate pumps can be arranged downstream of the dialyzer. The pump speed of the dialysate pump can be controlled to manage the flow of dialysate through the dialyzer and to control the rate of ultrafiltration during dialysis treatment. For example, downstream pump 915 may be controlled to a faster pump speed than upstream pump 917 in order to remove fluid from the patient.

如上所述,类似于生理盐水源的反冲流体源901优选地与自动控制阀连接到血液回路。然而,与先前的解决方案不同,这种反冲流体源在运输时是空的。在一个实施例中,该反冲流体源可以预连接到血液管组,不像生理盐水袋必须通过“尖头”连接器接近(这引入了污染和/或用户伤害的风险)。在一些实施例中,该袋的优选容量为大约500mL,并且至少250mL,这通常是反冲所需的流体的实际体积。As noted above, the backflush fluid source 901, similar to a saline source, is preferably connected to the blood circuit with an automatic control valve. However, unlike previous solutions, this recoil fluid source is shipped empty. In one embodiment, this source of backflush fluid may be pre-connected to the blood tubing set, unlike saline bags which must be accessed through a "tip" connector (which introduces the risk of contamination and/or user injury). In some embodiments, the preferred capacity of the bag is about 500 mL, and at least 250 mL, which is typically the actual volume of fluid required for backflushing.

如图9A所示,管组通过透析器926连接到透析液回路,透析器926包括分隔两个隔室的半透膜(允许血液过滤)。在优选的实施例中,系统的透析液是实时产生的,并且优选地由分解的粉末或液体组分产生。透析系统可以包括透析液混合系统,该透析液混合系统包括可变比例能力。例如,在灌注期间,可以向透析液中加入较低浓度的碳酸氢盐缓冲液,以便更接近地模拟生理盐水的组成。在一些实施例中,透析液回路能够从血液回路中去除流体(在正常治疗过程中需要从患者体内去除多余的流体),以及将流体推入血液回路中,用于灌注、团注(boluses)和反冲。As shown in Figure 9A, the tubing set is connected to the dialysate circuit through a dialyzer 926 comprising a semipermeable membrane (allowing blood filtration) separating the two compartments. In preferred embodiments, the system's dialysate is generated in real time, and preferably from decomposed powder or liquid components. The dialysis system may include a dialysate mixing system that includes a variable ratio capability. For example, lower concentrations of bicarbonate buffer can be added to the dialysate during perfusion to more closely mimic the composition of saline. In some embodiments, the dialysate circuit is capable of removing fluid from the blood circuit (excess fluid needs to be removed from the patient during normal therapy) and pushing fluid into the blood circuit for perfusion, boluses and recoil.

作为灌注序列的一部分,透析系统被配置成使透析液反过滤通过透析器进入血液回路。为了使透析液反过滤通过透析器,上游泵917可以被控制为比下游泵915更快的泵速。通向反冲流体源901的阀(例如生理盐水阀911)可以被控制为打开,并且反冲流体袋将以反过滤的灌注透析液填充。一旦预定量的流体被泵入反冲流体源,阀911就可以被控制以关闭或闭塞生理盐水管线,并保持关闭,直到反冲准备开始。这样,如果机器的透析液回路出现故障,则仍然可以使用反冲袋中预先填充的流体进行血液回流。有时有必要丢弃接触透析器的初始量的灌注流体(priming fluid),以冲洗出灭菌残留化学物质。在这种情况下,在灌注开始时,通向反冲流体源的阀911在灌注开始时关闭,并且血液回路被灌注而不填充反冲袋。然后,血液回路灌注流体被丢弃,然后用新的反过滤的透析液替换。在这一点上,在灌注丢弃序列之后,向反冲袋的阀可以被打开,并且袋可以用反冲透析液流体填充。As part of the perfusion sequence, the dialysis system is configured to back-filter dialysate through the dialyzer into the blood circuit. The upstream pump 917 can be controlled to a faster pump speed than the downstream pump 915 in order to backfilter the dialysate through the dialyzer. A valve to the backflush fluid source 901 (eg, saline valve 911 ) can be controlled to open, and the backflush fluid bag will fill with back-filtered perfusate. Once a predetermined amount of fluid has been pumped into the backflush fluid source, valve 911 may be controlled to close or occlude the saline line and remain closed until backflush is ready to begin. This way, if the machine's dialysate circuit fails, blood return can still be performed using the pre-filled fluid in the backflush bag. It is sometimes necessary to discard the initial volume of priming fluid that contacted the dialyzer in order to flush out the sterilization residual chemicals. In this case, at the start of priming, the valve 911 to the source of backflush fluid is closed at the start of priming, and the blood circuit is primed without filling the backflush bag. The blood circuit perfusion fluid is then discarded and replaced with fresh back-filtered dialysate. At this point, following the priming discard sequence, the valve to the backflush bag can be opened and the bag can be filled with backflush dialysate fluid.

图10是描述在治疗期间透析液回路出现故障的情况下,在反冲流体源中使用反过滤透析液以将血液返回患者的方法的流程图。在步骤1002,通向反冲储存容器(例如反冲流体源901)的流体管线可以被解除闭塞或打开。这可以通过例如打开流体管线的夹管阀(例如生理盐水管线的阀911)来实现。在步骤1004,透析液可以被反过滤通过透析器到流体管线中并进入反冲储存容器中。在步骤1006,可以完成透析治疗。可替代地,透析液回路可能遇到故障情况。最后,在步骤1008,可以使用反冲储存容器中的反过滤的透析液对患者进行血液回流。在一些实施例中,在非常长的治疗(例如,长于24小时)的情况下,可能需要周期性地更新流体以消除对微生物生长的担忧。在该实施例中,来自流体源的所有流体可以通过透析器泵出流体源以排出,并且然后可以启动上述相同的过程以重新填充流体源。10 is a flowchart describing a method of using back-filtered dialysate in a back-flush fluid source to return blood to a patient in the event of a dialysate circuit failure during therapy. At step 1002, a fluid line to a recoil storage container (eg, recoil fluid source 901) may be unblocked or opened. This can be accomplished, for example, by opening a pinch valve of a fluid line, such as valve 911 of the saline line. At step 1004, the dialysate may be back-filtered through the dialyzer into a fluid line and into a backflush storage container. At step 1006, the dialysis treatment may be completed. Alternatively, the dialysate circuit may experience a fault condition. Finally, at step 1008, the patient may be backflushed using the back-filtered dialysate in the backflush storage container. In some embodiments, in the case of very long treatments (eg, longer than 24 hours), it may be necessary to periodically refresh the fluid to address concerns about microbial growth. In this embodiment, all fluid from the fluid source can be pumped out of the fluid source through the dialyzer to drain, and then the same process described above can be initiated to refill the fluid source.

当特征或元件在本文被提及为在另一特征或元件“上”时,它可以直接在其他特征或元件上,或也可以存在中间的特征或元件。相反,当特征或元件被提及为“直接在另一特征或元件上”时,没有中间的特征或元件存在。还将理解,当特征或元件被提及为“连接”、“附接”或“联接”到另一特征或元件时,它可以直接连接、附接或联接到其他特征或元件,或可以存在中间的特征或元件。相反,当特征或元件被提及为“直接连接”、“直接附接”或“直接联接”到另一特征或元件时,没有中间的特征或元件存在。虽然针对一个实施例进行了描述或示出,但是这样描述或示出的特征和元件可以应用于其他实施例。本领域技术人员还将认识到,对“相邻”另一特征设置的结构或特征的引用可具有与相邻特征重叠或在相邻特征下方的部分。When a feature or element is referred to herein as being "on" another feature or element, it can be directly on the other feature or element, or intervening features or elements may also be present. In contrast, when a feature or element is referred to as being "directly on" another feature or element, there are no intervening features or elements present. It will also be understood that when a feature or element is referred to as being "connected," "attached" or "coupled" to another feature or element, it can be directly connected, attached or coupled to the other feature or element, or there can be present An intermediate feature or element. In contrast, when a feature or element is referred to as being "directly connected," "directly attached" or "directly coupled" to another feature or element, there are no intervening features or elements present. Although described or illustrated with respect to one embodiment, the features and elements so described or illustrated may apply to other embodiments. Those skilled in the art will also recognize that references to a structure or a feature that is disposed "adjacent" to another feature may have portions that overlap or underlie the adjacent feature.

本文使用的术语仅用于描述特定实施例的目的,并且不意图限制本发明。例如,如本文所用的,单数形式“a(一)”、“an(一)”和“the(所述)”旨在也包括复数形式,除非上下文以其他方式明确说明。应当进一步理解,术语“包括(comprises)”和/或“包括(comprising)”当在本说明书中使用时指定所陈述的特征、步骤、操作、元件和/或部件的存在,但不排除存在或添加一个或更多个其他特征、步骤、操作、元件、部件和/或它们的组。如本文所用的,术语“和/或”包括相关联的所列项中的一个或更多个项的任意组合和所有组合,并且可缩写为“/”。The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms "a", "an", and "the" are intended to include the plural forms as well, unless the context clearly dictates otherwise. It should be further understood that the terms "comprises" and/or "comprising" when used in this specification specify the presence of stated features, steps, operations, elements and/or parts, but do not exclude the presence or Add one or more other features, steps, operations, elements, parts and/or groups thereof. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items, and may be abbreviated as "/".

为了便于描述,在本文中可使用空间相关的术语,诸如“在...下方(under)”、“在...下(below)”、“下部(lower)”、“在...上方(over)”、“上部(upper)”等,以描述如附图所图示的一个元件或特征与其他元件或特征的关系。应理解的是,空间相关的术语旨在包含除了附图中描绘的定向之外的装置在使用或操作中的不同定向。例如,如果附图中的装置被倒置,则被描述为“在其他元件或特征下方”或者“在其他元件或特征下面”的元件然后将被定向成“在其他元件或特征上方”。因此,示例性术语“在...下方”可包含“在...上方”和“在...下方”两种定向。该装置可以被另外地定向(旋转90度或以其他定向),并且本文使用的空间相关的描述词据此被解释。类似地,除非以其他方式特别说明,否则术语“向上(upwardly)”、“向下(downwardly)”、“竖直(vertical)”、“水平(horizontal)”等在本文中用于说明的目的。For ease of description, spatially relative terms such as "under", "below", "lower", "above" may be used herein (over)", "upper (upper)", etc., to describe the relationship between one element or feature and other elements or features as illustrated in the drawings. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if the device in the figures is turned over, elements described as "below" or "beneath" other elements or features would then be oriented "above" the other elements or features. Thus, the exemplary term "below" can encompass both an orientation of "above" and "beneath". The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms "upwardly," "downwardly," "vertical," "horizontal," etc. are used herein for purposes of description unless specifically stated otherwise .

虽然术语“第一”和“第二”在本文中可以用于描述各种特征/元件(包括步骤),但是这些特征/元件不应该受这些术语的限制,除非上下文另有说明。这些术语可以用于将一个特征/元件与另一个特征/元件区分开。因此,在不脱离本发明的教导的情况下,下面讨论的第一特征/元件可以被称为第二特征/元件,并且类似地,下面讨论的第二特征/元件可以被称为第一特征/元件。Although the terms "first" and "second" may be used herein to describe various features/elements (including steps), these features/elements should not be limited by these terms unless the context dictates otherwise. These terms can be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and, similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention. /element.

在本说明书和所附权利要求书中,除非上下文另有要求,否则术语“包括(comprise)”及其诸如“包括(comprises)”和“包括(comprising)”的变型意味着可以在方法和制品(例如,组成和设备,包括装置和方法)中共同使用各种部件。例如,术语“包括(comprising)”将被理解为暗示包含任何所述的元件或步骤,但不排除任何其他元件或步骤。In this specification and the appended claims, unless the context requires otherwise, the term "comprise" and variations thereof such as "comprises" and "comprising" mean elements that may be included in methods and articles of manufacture. Various components are commonly used in (for example, compositions and devices, including devices and methods). For example, the term "comprising" will be understood to imply the inclusion of any stated elements or steps, but not the exclusion of any other elements or steps.

如本文在说明书和权利要求书中所使用的,包括在示例中所使用的并且除非另有明确说明,所有数字可被当作前面有词语“约(about)”或“大约(approximately)”,即使该术语没有明确出现。可以在描述幅度和/或位置时使用短语“约”或“大约”,以指示所描述的值和/或位置在值和/或位置的合理预期范围内。例如,数值可以具有为所陈述的值(或值的范围)的+/-0.1%、所陈述的值(或值的范围)的+/-1%、所陈述的值(或值的范围)的+/-2%、所陈述的值(或值的范围)的+/-5%、所陈述的值(或值的范围)的+/-10%等的值。本文给出的任何数值还应当理解为包括约或大约该值,除非上下文另有说明。例如,如果值“10”被公开,则“约10”也被公开。本文列举的任何数值范围旨在包括包含在其中的所有子范围。还应当理解,当一个值被公开时,也公开了“小于或等于”该值、“大于或等于该值”以及值之间的可能范围,如本领域技术人员适当地理解的。例如,如果公开了值“X”,则也公开了“小于或等于X”以及“大于或等于X”(例如,其中X是数值)。还应当理解,在整个申请中,以多种不同的格式提供数据,并且该数据表示数据点的任何组合的端点和起始点以及范围。例如,如果公开了特定数据点“10”和特定数据点“15”,则应当理解,大于、大于或等于、小于、小于或等于、和等于10和15以及在10和15之间被认为是公开的。还应当理解,还公开了两个特定单位之间的每个单位。例如,如果公开了10和15,则也公开了11、12、13以及14。As used herein in the specification and claims, including in the examples and unless expressly stated otherwise, all numbers may be read as preceded by the word "about" or "approximately", Even if the term doesn't appear explicitly. The phrases "about" or "approximately" may be used in describing magnitude and/or location to indicate that the described value and/or location is within a reasonably expected range of value and/or location. For example, a numerical value may have +/- 0.1% of a stated value (or range of values), +/- 1% of a stated value (or range of values), a stated value (or range of values) +/- 2% of a stated value (or range of values), +/- 5% of a stated value (or range of values), +/- 10% of a stated value (or range of values), etc. Any numerical value given herein should also be understood to include about or approximately that value, unless the context dictates otherwise. For example, if the value "10" is disclosed, then "about 10" is also disclosed. Any recitation of a numerical range herein is intended to include all subranges subsumed therein. It is also understood that when a value is disclosed, "less than or equal to" the value, "greater than or equal to the value" and possible ranges between values are also disclosed, as appropriately understood by those skilled in the art. For example, if the value "X" is disclosed, then "less than or equal to X" and "greater than or equal to X" are also disclosed (eg, where X is a numerical value). It should also be understood that throughout this application, data is provided in a variety of different formats and that this data represents endpoints and starting points and ranges for any combination of data points. For example, if a specific data point "10" and a specific data point "15" are disclosed, it should be understood that greater than, greater than or equal to, less than, less than or equal to, and equal to 10 and 15 and between 10 and 15 are considered to be public. It is also understood that every unit between two specific units is also disclosed. For example, if 10 and 15 are disclosed, then 11, 12, 13 and 14 are also disclosed.

虽然上面描述了各种说明性实施例,但是在不脱离如权利要求所描述的本发明的范围的情况下,可以对各种实施例进行若干改变中的任一个。例如,在替代实施例中,通常可以改变执行各种所描述的方法步骤的顺序,并且在其他替代实施例中,可以一起跳过一个或更多个方法步骤。各种装置和系统实施例的可选特征可以被包括在一些实施例中而不被包括在其他实施例中。因此,前面的描述主要被提供用于示例性目的,并且不应被解释为限制如在权利要求中阐述的本发明的范围。While various illustrative embodiments have been described above, any of several changes may be made to the various embodiments without departing from the scope of the present invention as described in the claims. For example, the order of performing various described method steps may generally be varied in alternative embodiments, and in other alternative embodiments, one or more method steps may be skipped altogether. Optional features of the various apparatus and system embodiments may be included in some embodiments and not in others. Accordingly, the foregoing description is provided mainly for exemplary purposes and should not be construed as limiting the scope of the invention as set forth in the claims.

本文所包括的示例和说明通过说明而非限制的方式示出其中可以实践主题的具体实施例。如所提到的,可以利用和从其导出其他实施例,使得可以做出结构和逻辑替换和改变而不脱离本公开的范围。仅为了方便,本发明性主题的这样的实施例在本文中可单独地或共同地由术语“发明”来指代,并且如果实际上多于一个被公开的话,不旨在将本申请的范围主动地限制为任何单个发明或发明概念。因此,虽然本文已经示出和描述了特定实施例,但是被认为实现相同目的的任何布置也可以替代所示的特定实施例。本公开旨在覆盖各种实施例的任何和所有修改或变型。在阅读以上描述后,本领域的技术人员将明白以上实施例的组合以及本文未具体描述的其他实施例。The examples and descriptions included herein show specific embodiments in which the subject matter may be practiced by way of illustration and not limitation. As mentioned, other embodiments may be utilized and derived therefrom, such that structural and logical substitutions and changes may be made without departing from the scope of this disclosure. Such embodiments of the inventive subject matter may be referred to herein, individually or collectively, by the term "invention" for convenience only, and it is not intended to limit the scope of this application if more than one are actually disclosed. Limitations are positively limited to any single invention or inventive concept. Therefore, although specific embodiments have been shown and described herein, any arrangement that is considered to achieve the same purpose may be substituted for the specific embodiments shown. This disclosure is intended to cover any and all adaptations or variations of various embodiments. Combinations of the above embodiments, and other embodiments not specifically described herein, will be apparent to those of skill in the art upon reading the above description.

Claims (24)

1. A method of improving the performance of a dialysis tubing, the dialysis tubing comprising an arterial line and further comprising a fluid delivery line connecting a fluid source to the dialysis tubing, the method comprising the steps of:
occlusion of the arterial line of the dialysis tubing;
opening or releasing a clamping mechanism engaged with the fluid delivery line;
regulating a pump speed of a blood pump engaged with the dialysis tubing to increase a fluid pressure within the dialysis tubing; and
fluid is delivered from the fluid source through the fluid delivery line into the dialysis tubing.
2. The method of claim 1, wherein regulating the pump speed of the blood pump comprises increasing a flow rate of the blood pump from a first flow rate to a second flow rate.
3. The method of claim 1, wherein regulating the pump speed of the blood pump comprises reducing a flow rate of the blood pump from a first flow rate to a second flow rate.
4. The method of claim 1, wherein regulating the pump speed of the blood pump comprises pulsing a flow rate of the blood pump.
5. The method of claim 1, wherein regulating the pump speed of the blood pump comprises reducing a flow rate of the blood pump from about 320ml/min to about 180ml/min.
6. The method of claim 1, further comprising automatically scheduling the occluding step, the opening step, and the modulating step to occur periodically during the dialysis treatment.
7. The method of claim 1, wherein a portion of the fluid delivery line remains occluded after opening or releasing the clamping mechanism due to the pre-extension clamping of the fluid delivery line.
8. The method of claim 1, wherein a portion of the fluid delivery line remains partially occluded after opening or releasing the clamping mechanism due to the front extension clamping of the fluid delivery line.
9. The method according to claim 1, further comprising the method steps of:
unblocking the arterial line;
closing or compressing the clamping mechanism in engagement with the fluid delivery line; and
dialysis treatment is initiated.
10. A dialysis system comprising:
a fluid source;
a dialysis tubing set comprising at least an arterial line, a blood pump portion and a fluid delivery line connecting the fluid source to the dialysis tubing set;
a blood pump configured to engage with the blood pump portion of the dialysis tubing set;
A first clamping mechanism configured to engage the arterial line;
a second clamping mechanism configured to engage the fluid delivery line; and
an electronic controller configured to control operation of the blood pump, the first clamping mechanism, and the second clamping mechanism, wherein during a priming sequence, the electronic controller is configured to:
closing or occluding the first clamping mechanism;
opening or unblocking the second clamping mechanism;
the pump speed of the blood pump is regulated to increase the fluid pressure within the dialysis tubing set and to deliver fluid from the fluid source through the fluid delivery line into the dialysis tubing.
11. The system of claim 10, wherein the electronic controller is configured to regulate the pump speed of the blood pump by increasing a flow rate of the blood pump from a first flow rate to a second flow rate.
12. The system of claim 10, wherein the electronic controller is configured to regulate the pump speed of the blood pump by reducing a flow rate of the blood pump from a first flow rate to a second flow rate.
13. The system of claim 10, wherein the electronic controller is configured to regulate the pump speed of the blood pump by pulsing a flow rate of the blood pump.
14. The system of claim 10, wherein the electronic controller is configured to regulate the pump speed of the blood pump, including reducing a flow rate of the blood pump from about 320ml/min to about 180ml/min.
15. The system of claim 10, wherein the controller is configured to automatically perform the closing step, the opening step, and the regulating step periodically during a dialysis treatment.
16. The system of claim 10, wherein a portion of the fluid delivery line remains occluded after opening or releasing the clamping mechanism due to the front extension clamping of the fluid delivery line.
17. The system of claim 10, wherein a portion of the fluid delivery line remains partially occluded after opening or releasing the clamping mechanism due to the front extension clamping of the fluid delivery line.
18. The system of claim 10, wherein the electronic controller is further configured to:
Unblocking the arterial line;
closing or compressing the clamping mechanism in engagement with the fluid delivery line; and
dialysis treatment is initiated.
19. A method of improving the performance of a dialyzer during dialysis treatment, comprising the steps of:
starting dialysis treatment;
detecting a pressure difference between a blood side of the dialyzer and a dialysate side of the dialyzer;
if the pressure differential exceeds a predetermined threshold, then:
occlusion of the arterial line of the dialysis tubing;
opening or releasing a clamping mechanism engaged with the fluid delivery line;
regulating a pump speed of a blood pump engaged with the dialysis tubing to increase a fluid pressure within the dialysis tubing; and
fluid is delivered from a fluid source through the fluid delivery line into the dialysis tubing.
20. The method of claim 19, wherein regulating the pump speed of the blood pump comprises increasing a flow rate of the blood pump from a first flow rate to a second flow rate.
21. The method of claim 19, wherein regulating the pump speed of the blood pump comprises reducing a flow rate of the blood pump from a first flow rate to a second flow rate.
22. The method of claim 19, wherein regulating the pump speed of the blood pump comprises pulsing a flow rate of the blood pump.
23. A method of returning blood to a patient after a dialysis treatment using a dialysis system comprising a fluid delivery line connecting a fluid receptacle to a dialysis tubing set, the method comprising the steps of:
opening or releasing a clamping mechanism engaged with the fluid delivery line;
back-filtering dialysate through a dialyzer of the dialysis system, into the dialysis tubing set, and into the fluid receptacle via the fluid delivery line;
performing a dialysis treatment with the dialysis system, including drawing blood into the dialysis tubing set; and
the blood is returned to the patient with the back-filtered dialysate in the fluid receptacle.
24. The method of claim 23, wherein back filtering dialysate through the dialyzer further comprises controlling a first dialysate pump located upstream of the dialyzer to have a faster pump speed than a second dialysate pump located downstream of the dialyzer.
CN202180064900.0A 2020-08-05 2021-08-05 Dialysis systems and methods Pending CN116234590A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063061623P 2020-08-05 2020-08-05
US63/061,623 2020-08-05
PCT/US2021/044691 WO2022031938A1 (en) 2020-08-05 2021-08-05 Dialysis system and methods

Publications (1)

Publication Number Publication Date
CN116234590A true CN116234590A (en) 2023-06-06

Family

ID=80115746

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202180064900.0A Pending CN116234590A (en) 2020-08-05 2021-08-05 Dialysis systems and methods

Country Status (8)

Country Link
US (1) US20220040389A1 (en)
EP (1) EP4192541A4 (en)
JP (1) JP2023538525A (en)
CN (1) CN116234590A (en)
AU (1) AU2021320862A1 (en)
BR (1) BR112023002152A2 (en)
CA (1) CA3188421A1 (en)
WO (1) WO2022031938A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118236572A (en) * 2024-02-19 2024-06-25 中国人民解放军海军军医大学第三附属医院 Blood pressurization ultrafiltration device for nephrology department

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018035520A1 (en) 2016-08-19 2018-02-22 Outset Medical, Inc. Peritoneal dialysis system and methods
AU2021376314A1 (en) * 2020-11-09 2023-06-15 Outset Medical, Inc. Dialysis system and methods

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4828543A (en) * 1986-04-03 1989-05-09 Weiss Paul I Extracorporeal circulation apparatus
JPH06261938A (en) * 1992-07-07 1994-09-20 Senko Ika Kogyo Kk Dialytic device and blood returning method
US8029454B2 (en) * 2003-11-05 2011-10-04 Baxter International Inc. High convection home hemodialysis/hemofiltration and sorbent system
JP4889297B2 (en) * 2005-12-19 2012-03-07 株式会社ジェイ・エム・エス Hemodialysis machine
WO2008064174A1 (en) * 2006-11-17 2008-05-29 National Quality Care, Inc. Enhanced clearance in an artificial kidney incorporating a pulsatile pump
US8105266B2 (en) * 2007-07-05 2012-01-31 Baxter International Inc. Mobile dialysis system having supply container detection
JP2009017979A (en) * 2007-07-10 2009-01-29 Aruze Corp Game machine
WO2009086203A2 (en) * 2007-12-27 2009-07-09 Aethlon Medical, Inc. Method and apparatus for increasing contaminant clearance rates during extracorporeal fluid treatment
KR101628412B1 (en) * 2008-06-26 2016-06-08 감브로 룬디아 아베 Methods and devices for monitoring the integrity of a fluid connection and computer readable storage medium
US9925323B2 (en) * 2009-12-17 2018-03-27 Gambro Lundia Ab Apparatus for extracorporeal blood treatment and method of operation
JP6813484B2 (en) * 2015-06-24 2021-01-13 日機装株式会社 Blood purification device
US12201762B2 (en) * 2018-08-23 2025-01-21 Outset Medical, Inc. Dialysis system and methods

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118236572A (en) * 2024-02-19 2024-06-25 中国人民解放军海军军医大学第三附属医院 Blood pressurization ultrafiltration device for nephrology department

Also Published As

Publication number Publication date
WO2022031938A1 (en) 2022-02-10
CA3188421A1 (en) 2022-02-10
EP4192541A4 (en) 2024-07-31
AU2021320862A1 (en) 2023-03-02
JP2023538525A (en) 2023-09-08
BR112023002152A2 (en) 2023-05-02
EP4192541A1 (en) 2023-06-14
US20220040389A1 (en) 2022-02-10

Similar Documents

Publication Publication Date Title
US7214312B2 (en) Fluid circuits, systems, and processes for extracorporeal blood processing
TWI593432B (en) An ambulatory ultrafiltration device, related methods and a computer program product
CN111526900B (en) Automatic extracorporeal blood processing device
CN116234590A (en) Dialysis systems and methods
US20220203004A1 (en) Dialysis systems and methods
AU2024204207B2 (en) Apparatus for extracorporeal blood treatment
JP2021533881A (en) Dialysis system and method
US10940256B2 (en) Hemodialysis system
US20250099659A1 (en) Dialysis transfer set having filter integrity testing
US20230201432A1 (en) Determining a Volume of a Container for Dialysis Treatment
JP2023517466A (en) Method and device for determining when to collect pressure measurements

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
OSZAR »